The use of transdermal nicotine in smoking cessation. 1990

P Müller, and T Abelin, and R Ehrsam, and P Imhof, and H Howald, and D Mauli
Pharmaceutical Division, CIBA-GEIGY Ltd., Basle, Switzerland.

The transdermal administration of nicotine by means of a transdermal nicotine system (TNS) affords a novel way of nicotine replacement to alleviate smoking cessation. The plasma levels of nicotine maintained with the TNS are in the range of the footpoint concentrations observed in smokers. The efficacy of the TNS was investigated in two placebo-controlled double-blind smoking cessation programs with minimal contact and minimal psychological support. A total of 311 smokers were treated for 3 months or 9 weeks. The abstinence rates at the end of the treatment and weaning periods were almost doubled in the TNS groups (36% and 39%) as compared to the placebo groups (23% and 20%) with a significant difference for both studies (p less than 0.05). These data suggest that the TNS can also improve the smoking cessation rates under the conditions of general medical advice, making it suitable for use outside of specialized smoking cessation centers.

UI MeSH Term Description Entries
D008297 Male Males
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits
D013557 Switzerland A country in Europe. It is bordered by Austria, France, Italy, Liechtenstein, and Germany. The capital is Bern.
D016032 Randomized Controlled Trials as Topic Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical

Related Publications

P Müller, and T Abelin, and R Ehrsam, and P Imhof, and H Howald, and D Mauli
March 1990, Clinical pharmacology and therapeutics,
P Müller, and T Abelin, and R Ehrsam, and P Imhof, and H Howald, and D Mauli
April 1994, The American journal of psychiatry,
P Müller, and T Abelin, and R Ehrsam, and P Imhof, and H Howald, and D Mauli
June 1992, American family physician,
P Müller, and T Abelin, and R Ehrsam, and P Imhof, and H Howald, and D Mauli
January 1992, The New England journal of medicine,
P Müller, and T Abelin, and R Ehrsam, and P Imhof, and H Howald, and D Mauli
January 1992, The New England journal of medicine,
P Müller, and T Abelin, and R Ehrsam, and P Imhof, and H Howald, and D Mauli
January 1992, The New England journal of medicine,
P Müller, and T Abelin, and R Ehrsam, and P Imhof, and H Howald, and D Mauli
February 1998, The Annals of pharmacotherapy,
P Müller, and T Abelin, and R Ehrsam, and P Imhof, and H Howald, and D Mauli
January 2003, Lijecnicki vjesnik,
P Müller, and T Abelin, and R Ehrsam, and P Imhof, and H Howald, and D Mauli
September 1995, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
P Müller, and T Abelin, and R Ehrsam, and P Imhof, and H Howald, and D Mauli
June 1994, The Southeast Asian journal of tropical medicine and public health,
Copied contents to your clipboard!